The Drug Discovery & Therapy World Congress 2017 will host leading scientists from the academia and industry worldwide, to discuss the latest developments in drug discovery and therapy and promises to be a large event with up to 400 lectures in 40 thematic sessions with an allied poster presentation.
At the 2017 congress the major topics of discussion related to drug, discovery and therapy will include: Pharmaceutical Research & Development, Translational Medicine, Regenerative Medicine, Enabling Technologies, Structural Biology, Drug Delivery & Targeting, Anti-infectives, Biologics, CNS Drug Discovery & Therapy, Diabetes and Obesity Drug Discovery & Therapy, Women's Health Drug Discovery & Therapy, Drug Discovery in Preclinical Research, Cardiovascular Drug Discovery & Therapy, Oncology, Process Chemistry and Drug Manufacturing, Pulmonary Drug Discovery & Therapy, Recent Advances in Patient Treatment and Care, Inflammation and Immunology, Innovative Drug Discovery and Nanotechnology, Pharmaceutical Biotechnology, Proteomics & Bioinformatics, Pharmacogenomics, Protein and Peptide Sciences, Drug Metabolism, Hot Topics in Medicinal Chemistry, Medical Imaging, Hot Topics in HIV Research, In-silico Drug Design and in-silico screening, Combinatorial Chemistry, High-throughput Screening & Laboratory automation, Hot Topics in Drug Targets, Hot Topics in Natural Products, Stereoselective Synthesis of Bioactive Compounds, Recent Advances in Spectroscopy, Academic CRO/Industrial collaborations in drug discovery.
The conference aims to provide many interesting perspectives on how science and technology of drug discovery and drug therapy are changing rapidly, thereby providing new opportunities and challenges to scientists and medical doctors.
More information can be found on the conference website
